Aristeia Capital’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$590K Buy
7,907
+4,757
+151% +$342K 0.01% 392
2026
Q1
$224K Buy
+3,150
New +$215K ﹤0.01% 468
2025
Q3
Sell
-8,465
Closed -$365K 595
2025
Q2
$365K Sell
8,465
-291
-3% -$11.2K 0.01% 258
2025
Q1
$347K Buy
+8,756
New +$387K 0.01% 232

Other funds holding NGVT

Aristeia Capital's NGVT Position: Q2 2026 in Review

Aristeia Capital increased its Ingevity (NGVT) stake by 151% in Q2 2026, buying an estimated $342K and bringing the position to 7,907 shares worth $590K. The position accounts for 0.01% of the portfolio, ranked #392.

Aristeia Capital first reported a position in NGVT in Q1 2025 and has held it in 4 quarters since. 316 funds tracked by Wall St. Rank hold NGVT as of Q2 2026.

  • Aristeia Capital held 7,907 shares of Ingevity worth $590K as of Q2 2026.
  • Aristeia Capital bought 4,757 Ingevity shares in Q2 2026, an estimated $342K.
  • Ingevity made up 0.01% of Aristeia Capital's portfolio in Q2 2026, its #392 holding.
  • Aristeia Capital first reported a position in Ingevity in Q1 2025 and has held it in 4 quarters since.
  • 316 funds tracked by Wall St. Rank held Ingevity as of Q2 2026.

Based on Aristeia Capital's 13F filing for Q2 2026, filed 14 Aug 2026.